文献速递认知障碍与痴呆

解码疑似快速进展性痴呆患者进展、病因和结局相关的临床特征

Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia.
PubMed 文献 · Ann Neurol · 2025-06-20

该研究纳入248例疑似快速进展性痴呆(RPD)患者,在Mayo Clinic和Washington University随访,由两名痴呆专科医生独立诊断。185例(74.6%)符合RPD标准,RPD患者更年长,更常诊断为阿尔茨海默病及相关痴呆或克雅氏病,视觉失认、显著脑萎缩和周期性癫痫样放电仅见于RPD患者。控制年龄后,ICU入住、无癫痫发作、脑MRI异常和脑脊液白细胞≤5个/mm3与RPD独立相关,RPD患者更易死亡或进展为重度痴呆。

要点

  • 视觉失认、显著脑萎缩和周期性癫痫样放电仅见于符合RPD标准的患者。
  • 控制年龄后,ICU入住、无癫痫发作、脑MRI异常和脑脊液白细胞≤5个/mm3与RPD独立相关。
  • RPD患者更易死亡或进展为重度痴呆,平均结局时间36.1个月。

核心结论

  • 特定的临床特征可识别疑似RPD患者中可能继续 decline 的人群,早期识别这些特征可能提高诊断准确性和预后判断。

主要发现

  • 248例疑似RPD患者中185例(74.6%)符合RPD标准。
  • RPD患者更年长(62.6 ± 14.5 vs 55.2 ± 18.1岁;p < 0.001)。
  • RPD患者更常诊断为阿尔茨海默病及相关痴呆(OR 3.13,95% CI 1.40,7.31)或克雅氏病(OR 4.67,95% CI 1.38,15.75)。
  • 视觉失认(15/183;8.2%)、显著脑萎缩(27/182;14.8%)和周期性癫痫样放电(11/151;7.3%)仅见于RPD患者。
  • 控制年龄后,ICU入住(OR 4.77,95% CI 1.61,14.12)、无癫痫发作(OR 2.47,95% CI 1.15,5.31)、脑MRI异常(OR 2.01,95% CI 0.997,4.05)和脑脊液白细胞≤5个/mm3(OR 3.30,95% CI 1.60,6.82)与RPD独立相关。

关键数值与推荐

  • RPD定义为症状出现后1年内发生痴呆或2年内丧失行为能力。
  • RPD患者更易死亡或进展为重度痴呆,平均结局时间36.1个月(95% CI 31.2-41.0)。

临床怎么用

  • 对疑似RPD患者,应关注视觉失认、显著脑萎缩、周期性癫痫样放电、ICU入住、无癫痫发作、脑MRI异常和脑脊液白细胞≤5个/mm3等特征以辅助识别可能继续进展的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the clinical features that identify patients with suspected rapidly progressive dementia (RPD) who will develop RPD. METHODS: Patients with suspected RPD were enrolled and followed at Mayo Clinic (Jacksonville, FL; January 2020 to October 2023) and Washington University (Saint Louis, MO; June 2016 to December 2019). Two dementia specialists independently reviewed clinical data and assigned diagnoses. Patients were diagnosed with RPD if they developed dementia within 1 year or incapacitation within 2 years of symptom onset. The associations between clinical features and causes and outcomes were explored via univariate and multivariate comparisons. RESULTS: Of 248 patients with suspected RPD, 185 (74.6%) met criteria for RPD. Patients with RPD were older (62.6 ± 14.5 vs 55.2 ± 18.1 years; p < 0.001), and more frequently diagnosed with Alzheimer's disease or related dementias (OR 3.13, 95% CI 1.40, 7.31) or Creutzfeldt-Jakob disease (OR 4.67, 95% CI 1.38, 15.75). Visual agnosia (15/183; 8.2%), substantial brain atrophy (27/182; 14.8%), and periodic epileptiform discharges (11/151; 7.3%) were exclusively detected in patients with RPD. After controlling for age, intensive care unit admission (OR 4.77, 95% CI 1.61, 14.12), lack of seizures (OR 2.47, 95% CI 1.15, 5.31), abnormal brain magnetic resonance imaging (OR 2.01, 95% CI 0.997, 4.05), and cerebrospinal fluid white blood cell count ≤5 cells/mm3 (OR 3.30, 95% CI 1.60, 6.82) were also independently associated with RPD. Patients with RPD were more likely to die or develop severe dementia (mean time to outcome, 36.1 months; 95% CI 31.2-41.0). INTERPRETATION: Selected clinical features may identify patients with suspected RPD who are likely to continue to decline. Early recognition of these features may improve diagnostic accuracy and inform prognosis. ANN NEUROL 2025;98:764-776.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Piura YD, Satyadev N, Corriveau-Lecavalier N, et al. Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia. Ann Neurol. 2025. PMID: 40539812. doi:10.1002/ana.27297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。